Company / Interest Expense
AYTU BIOPHARMA, INC Interest Expense History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$900.0K
FY2022
5-year range
$900.0K / $900.0K
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 6 years, ranging from $114,994 in FY2015 to $5M in FY2016.
Based on SEC 10-K filings.
$900,000 in FY2022 with a 5-year CAGR of -18.7%.
Increased from $749,423 to $900,000 over the past 4 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -18.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.7%, indicating a declining trend.
- Peak interest expense was recorded in FY2016.
- Lowest interest expense in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $900.0K | - |
| FY2021 | - | - |
| FY2020 | $2.6M | +247.8% |
| FY2018 | $749.4K | -70.4% |
| FY2017 | $2.5M | -53.8% |
| FY2016 | $5.5M | +4675.5% |
| FY2015 | $115.0K | +356.4% |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026